Professor of Medicine
Lunenfeld Tanenbaum Research
Institute of Mt. Sinai Hospital
University of Toronto
Toronto, Ontario, Canada
For unparalleled scientific contributions to endocrinology, physiology, and metabolism, including the elucidation of glucagon-like peptide (GLP) function in modulating insulin secretion, blood glucose levels, appetite regulation, and nutrient absorption. Dr. Drucker’s innovative research has laid the foundation for the development of novel therapeutics for diabetes, obesity, neurodegenerative diseases, short bowel syndrome, and inflammatory bowel and cardiometabolic disorders. His pioneering discoveries continue to shape metabolic research and may serve as a catalyst for future advancements in cancer biology and therapeutics.
This award acknowledges an individual whose outstanding personal innovation in science and whose position as a thought leader in fields relevant to cancer research has the potential to inspire creative thinking and new directions in cancer research. The recipient is selected by the AACR president. To learn more please visit the press release.
View Past Recipients.